Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

grape insurance AG

History from 26 Nov 2021

UID
CHE-313.051.787
Legal form
AG
Canton
ZH
Founded
26 Nov 2021
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 231k
58k115k173k231k4 May 2022 · CHF 125k25 Jan 2024 · CHF 180k19 May 2026 · CHF 231k20222023202420252026
  • shares
  • Vorzugsaktien Pre-Seed
  • Vorzugsaktien Seed
  • Vorzugsaktien A

Record

  1. Company formed

    Founded 26 Nov 2021

    SHAB HR01-1005346082 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 124’997
    Shares
    100’000 → 124’997
    New shares, % of post-step shares
    20.0% (24’997 new)

    Aktienkapital neu: CHF 124'997.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 124'997.00 [bisher: CHF 100'000.00]. Aktien neu: 124'997 Namenaktien zu CHF 1.00 [bisher: 100'000 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 14.04.2022 die mit Beschluss vom 23.11.2021 eingeführte Bestimmung betreffend bedingter Kapitalerhöhung gemäss näherer Umschreibung in den Statuten geändert.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005464317 ↗
  3. Capital increase

    Not assessed

    Issued from conditional capital

    Nominal capital
    124’997 → 179’952
    Shares
    124’997 → 179’952
    New shares, % of post-step shares
    30.5% (54’955 new)
    Share classes
    106’097 × CHF 1 · 24’997 × CHF 1 Vorzugsaktien Pre-Seed · 48’858 × CHF 1 Vorzugsaktien Seed

    Aktienkapital neu: CHF 179'952.00 [bisher: CHF 124'997.00]. Liberierung Aktienkapital neu: CHF 179'952.00 [bisher: CHF 124'997.00]. Aktien neu: 106'097 Namenaktien zu CHF 1.00, 24'997 Namenaktien zu CHF 1.00 (Vorzugsaktien Pre-Seed) und 48'858 Namenaktien zu CHF 1.00 (Vorzugsaktien Seed) [bisher: 124'997 Namenaktien zu CHF 1.00]. [bisher: Die Gesellschaft hat mit Beschluss vom 14.04.2022 die mit Beschluss vom 23.11.2021 eingeführte Bestimmung betreffend bedingter Kapitalerhöhung gemäss näherer Umschreibung in den Statuten geändert.].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005943476 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    179’952 → 230’597
    Shares
    179’952 → 230’597
    New shares, % of post-step shares
    22.0% (50’645 new)
    Share classes
    106’097 × CHF 1 · 24’997 × CHF 1 Vorzugsaktien Pre-Seed · 48’858 × CHF 1 Vorzugsaktien Seed · 50’645 × CHF 1 Vorzugsaktien A

    Aktienkapital neu: CHF 230'597.00 [bisher: CHF 179'952.00]. Liberierung Aktienkapital neu: CHF 230'597.00 [bisher: CHF 179'952.00]. Aktien neu: 106'097 Namenaktien zu CHF 1.00, 24'997 Namenaktien zu CHF 1.00 (Vorzugsaktien Pre-Seed), 48'858 Namenaktien zu CHF 1.00 (Vorzugsaktien Seed) und 50'645 Namenaktien zu CHF 1.00 (Vorzugsaktien A) [bisher: 24'997 Namenaktien zu CHF 1.00 (Vorzugsaktien Pre-Seed), 106'097 Namenaktien zu CHF 1.00 und 48'858 Namenaktien zu CHF 1.00 (Vorzugsaktien Seed)].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.95 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006653507 ↗

Published by 8 Oct 2026